In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price target of DKK900.00. The company’s shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback